Drugs giant AstraZeneca today upped its earnings guidance for the year after reporting a better-than-expected hike in third quarter profits.

Pharmaceuticals giant AstraZeneca today said full-year profits fell 4% after it counted the cost of a jobs cull and its battle against competition from cheaper generic drugs.